The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Oct. 27, 2016
Applicant:

Lieber Institute for Brain Development, Baltimore, MD (US);

Inventor:

Brady Maher, Baltimore, MD (US);

Assignee:

Lieber Institute, Inc., Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61P 25/18 (2006.01); G01N 33/50 (2006.01); A61K 45/06 (2006.01); A61K 31/4439 (2006.01); A61K 38/13 (2006.01); A61P 43/00 (2006.01); A61K 9/00 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
G01N 33/5058 (2013.01); A61K 9/0019 (2013.01); A61K 31/4439 (2013.01); A61K 38/13 (2013.01); A61K 45/06 (2013.01); A61P 25/18 (2018.01); A61P 43/00 (2018.01); C12Q 1/6883 (2013.01); G01N 2500/10 (2013.01);
Abstract

Provided are methods for treating and/or reducing the symptoms of a neurological or neurodevelopmental disease or disorder characterized by ectopic expression of certain ion channels, in particular, the Nav1.8 subtype SCN10a sodium channel, or the KCNQ1 potassium channel, in neuronal cells of the central nervous system (CNS) of a subject by administering to a subject in need an antagonist of one or both of these ion channels, and in particular, an antagonist of SCN10a, to block, reduce, or suppress the aberrant CNS neuronal ion channel expression and/or activity and normalize behavioral and cognitive defects associated with the neurological and neurodevelopmental disease or disorder, so as to treat and/or reduce the symptoms of the neurological or neurodevelopmental disease or disorder. Examples of such diseases or disorders that may be treated by the described methods include, for example, Pitt-Hopkins Syndrome (PTHS), autism, autism spectrum disorder, schizophrenia, 18q syndrome and the like.


Find Patent Forward Citations

Loading…